Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Tau PET performs well in predicting dementia in individuals with MCI
Jun 12, 2024
Tau positron emission tomography predicts all-cause dementia and Alzheimer disease dementia
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Vestibular system impairment tied to fall risk in Alzheimer’s patients
Mar 18, 2022
A significant association was seen between semicircular canal function with lower likelihood of falls in adjusted analysis.
Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
Home discharge down, mortality increased after ICU stay for dementia patients
Jul 17, 2023
Older adults with Alzheimer’s disease and related dementia have lower rates of home discharge and higher mortality.
Gantenerumab does not slow clinical decline in early Alzheimer’s disease
Nov 16, 2023
Two trials show a lower amyloid plaque burden with gantenerumab versus placebo at 116 weeks.
Adult education classes may lower dementia risk
Aug 30, 2023
Additionally, participation was tied to greater retention of subsequent fluid intelligence.
Higher pancreatic fat percentage linked to lower cognition in men
Feb 27, 2024
Higher pancreatic fat was linked to lower cognition and brain volumes in middle-aged men at high risk for Alzheimer’s disease.
Ultraprocessed food consumption linked to dementia risk
Jul 28, 2022
Replacing ultraprocessed foods weight in diet with an equivalent proportion of unprocessed or minimally processed foods may lower risk.